| Product Code: ETC9978986 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Veterinary Molecular Diagnostics Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Veterinary Molecular Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Veterinary Molecular Diagnostics Market - Industry Life Cycle |
3.4 United States (US) Veterinary Molecular Diagnostics Market - Porter's Five Forces |
3.5 United States (US) Veterinary Molecular Diagnostics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United States (US) Veterinary Molecular Diagnostics Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 United States (US) Veterinary Molecular Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing pet ownership and spending on pet healthcare in the US |
4.2.2 Growing awareness about zoonotic diseases and the need for early diagnosis in animals |
4.2.3 Technological advancements in molecular diagnostics leading to more accurate and efficient testing |
4.3 Market Restraints |
4.3.1 High costs associated with veterinary molecular diagnostics procedures |
4.3.2 Limited availability of skilled professionals in the field of veterinary molecular diagnostics |
4.3.3 Stringent regulatory requirements for product approvals and market entry |
5 United States (US) Veterinary Molecular Diagnostics Market Trends |
6 United States (US) Veterinary Molecular Diagnostics Market, By Types |
6.1 United States (US) Veterinary Molecular Diagnostics Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Veterinary Molecular Diagnostics Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United States (US) Veterinary Molecular Diagnostics Market Revenues & Volume, By Instruments, 2021- 2031F |
6.1.4 United States (US) Veterinary Molecular Diagnostics Market Revenues & Volume, By Reagents, 2021- 2031F |
6.1.5 United States (US) Veterinary Molecular Diagnostics Market Revenues & Volume, By Services, 2021- 2031F |
6.1.6 United States (US) Veterinary Molecular Diagnostics Market Revenues & Volume, By Software, 2021- 2031F |
6.2 United States (US) Veterinary Molecular Diagnostics Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Veterinary Molecular Diagnostics Market Revenues & Volume, By Veterinary Hospitals, 2021- 2031F |
6.2.3 United States (US) Veterinary Molecular Diagnostics Market Revenues & Volume, By Clinical Laboratories, 2021- 2031F |
6.2.4 United States (US) Veterinary Molecular Diagnostics Market Revenues & Volume, By Research Institutes, 2021- 2031F |
7 United States (US) Veterinary Molecular Diagnostics Market Import-Export Trade Statistics |
7.1 United States (US) Veterinary Molecular Diagnostics Market Export to Major Countries |
7.2 United States (US) Veterinary Molecular Diagnostics Market Imports from Major Countries |
8 United States (US) Veterinary Molecular Diagnostics Market Key Performance Indicators |
8.1 Adoption rate of molecular diagnostics tests in veterinary clinics |
8.2 Number of research and development collaborations in the US veterinary molecular diagnostics market |
8.3 Rate of incorporation of new technologies and assays in veterinary molecular diagnostics labs. |
9 United States (US) Veterinary Molecular Diagnostics Market - Opportunity Assessment |
9.1 United States (US) Veterinary Molecular Diagnostics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United States (US) Veterinary Molecular Diagnostics Market Opportunity Assessment, By Application, 2021 & 2031F |
10 United States (US) Veterinary Molecular Diagnostics Market - Competitive Landscape |
10.1 United States (US) Veterinary Molecular Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Veterinary Molecular Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here